Cargando…

Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?

Detalles Bibliográficos
Autores principales:	Arbyn, Marc, Bonde, Jesper, Cushieri, Kate, Poljak, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482297/ https://www.ncbi.nlm.nih.gov/pubmed/36114549 http://dx.doi.org/10.1186/s12967-022-03627-w

Ejemplares similares

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2022)

Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2023)

Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening
por: Heideman, Daniëlle A. M., et al.
Publicado: (2022)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening
por: Akbari, Ajmal, et al.
Publicado: (2018)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway—PaVDaG study)
por: Stanczuk, Grazyna, et al.
Publicado: (2016)

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
por: Bhatia, Ramya, et al.
Publicado: (2023)

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
por: Xu, Lan, et al.
Publicado: (2018)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study
por: Smith, Megan A, et al.
Publicado: (2022)

HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples
por: Cornall, Alyssa M., et al.
Publicado: (2017)

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework
por: Dhillon, Sharonjit K., et al.
Publicado: (2021)

Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales
por: Tatar, Ovidiu, et al.
Publicado: (2023)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
por: von Karsa, Lawrence, et al.
Publicado: (2015)

Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

False positive cervical HPV screening test results
por: Schiffman, Mark, et al.
Publicado: (2019)

Cervical Cancer Screening with HPV Testing: Updates on the Recommendation
por: Carvalho, Carla Fabrine, et al.
Publicado: (2022)

Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study
por: De Pauw, Hélène, et al.
Publicado: (2021)

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
por: Arbyn, Marc, et al.
Publicado: (2018)

Comparison of the performance of HPV DNA chip test and HPV PCR test in cervical cancer screening in rural China
por: Li, Zhi-Fang, et al.
Publicado: (2022)

Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2018)

HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer
por: Arbyn, Marc, et al.
Publicado: (2022)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
por: Chrysostomou, Andreas C., et al.
Publicado: (2018)

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
por: Wei, Baojun, et al.
Publicado: (2020)

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical
por: Mittendorf, Thomas, et al.
Publicado: (2007)

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
por: Arbyn, Marc, et al.
Publicado: (2009)

Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening
por: Yang, Qing, et al.
Publicado: (2022)

Cervical cancer screening by visual inspection and HPV testing in Eswatini
por: Ginindza, Themba G., et al.
Publicado: (2022)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
por: Zeferino, Luiz Carlos, et al.
Publicado: (2018)

Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas
por: Segura, Marcos Emanuel de Alcântara
Publicado: (2019)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

Oral/oropharyngeal “selfies” in gay and bisexual men: a pilot study exploring oropharyngeal screening for HPV-related possible malignancies
por: Ross, Michael W., et al.
Publicado: (2023)

Can HPV Test on Random Urine Replace Self-HPV Test on Vaginal Self-Samples or Clinician-Collected Cervical Samples?
por: Shih, Yu-Hsiang, et al.
Publicado: (2023)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)—study protocol of a randomised healthcare policy trial
por: Glinska, Patrycja, et al.
Publicado: (2023)

Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management
por: Bowden, Sarah J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8dsafj06uvioctgcqac09seav2